The success of Sildenafil initially sparked a period of growth for major pharmaceutical companies, however recent shifts present a uncertain picture for investors. Off-patent alternatives are eroding profits, and https://tiannaaqtd672788.blogdomago.com/39707212/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play